Sylke

Sylke

Develops biocompatible silk fibroin wound closure devices and dressings to improve surgical healing outcomes and reduce complications. 

Develops biocompatible silk fibroin wound closure devices and dressings to improve surgical healing outcomes and reduce complications. 

works image
Company Overview

Sylke produces SYLKE Skin Closure, a sterile single-use silk fibroin mesh strip with pressure-sensitive adhesive for topical skin closure and wound support. It is the first wound dressing made of pure hypoallergenic silk fibroin and is designed as a comfortable, breathable, water-resistant alternative to traditional sutures, staples, or glues for post-surgical incisions and lacerations.

Core themes: Medtech, Wound Care, Surgical, Biocompatible.

Why It Matters

Traditional wound closure methods can cause medical adhesive-related skin injuries, infections, and poor scarring outcomes. Sylke offers a natural, biocompatible solution that supports healing, simplifies application and removal, and improves patient comfort and long-term results.

Biocompatible natural silk fibroin for superior tissue compatibility

Reduces skin injuries, infections, and complications

Simple application with comfortable multi-day wear

works image
Vaark Perspective

Sylke reflects Vaark's focus on practical, clinician-designed medtech that solves everyday surgical workflow and outcome problems with biocompatible innovations that can immediately improve healing, reduce complications, and enhance the patient experience.

FAQs

What does Vaark invest in?

What stage and check size do you focus on?

How does Vaark evaluate companies?

What do founders get beyond capital?

Who is in the syndicate, and how do I join?

Why do you focus on workflow ownership?

FAQs

What does Vaark invest in?

What stage and check size do you focus on?

How does Vaark evaluate companies?

What do founders get beyond capital?

Who is in the syndicate, and how do I join?

Why do you focus on workflow ownership?

FAQs

What does Vaark invest in?

What stage and check size do you focus on?

How does Vaark evaluate companies?

What do founders get beyond capital?

Who is in the syndicate, and how do I join?

Why do you focus on workflow ownership?